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Background: The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) has been increasing in the
general population, and there is concern that close or physical contact, such as in professional and collegiate sports,
may increase spread of MRSA. We sought to determine the prevalence of MRSA colonization of male and female
athletes from 9 different sports at a major, Division I University during a 12-week period, and determine the USA
and SCCmec type from select isolates.
Methods: Swabs for culture of MRSA were obtained from nasal, axillary, and inguinal sites from healthy, asymptomatic
student athletes and support staff each week for 12 weeks. Select MRSA isolates were typed by pulsed field gel
electrophoresis (PFGE), and the genes encoding for MecA, cassette chromosome recombinase (Ccr), and several
toxins were determined by multiplex polymerase chain reaction (PCR). Discrepant results were clarified by
multi-locus sequence typing (MLST) and spa typing.
Results: Thirty-five percent (78/223) of test subjects were positive for MRSA during the study period, resulting in
isolation of 139 MRSA isolates. However, 47% (37/78) of MRSA-positive participants carried MRSA in axillary or
inguinal sites, but not in the anterior nares. There was significant correlation between MRSA carriage and participation in
wrestling (76%, 19/25; adjusted odds ratio 29.7, 95% CI 5.8-151.5) and baseball (44%, 17/39; adjusted odds ratio 4.4, 95% CI
1.1- 17.4), compared with a staff prevalence of 18.1% (4/22), but other factors were not examined. Multiplex PCR analysis
indicated that of the 32 isolates examined 26 could be typed, and all of these carried the SCCmec type IV cassette. PFGE
typing identified USA types 300, 400, 500, 700, and 800. However, one isolate was not a known USA type, but
was identified as a novel ST951 by MLST, and as spa type t216. Of the strains typed from the same individual,
there was consistency, but also variation and alternation of the SCCmec and spa types isolated from individual
subjects. Various staphylococcal toxin genes were identified in 31 of the 32 isolates analyzed.
Conclusions: Colonization by MRSA was greater in some student athletes than the average carriage rate for the
general population, and only 53% of MRSA carriers were identified by nasal cultures. Carriage of MRSA clones on
the same individual and transmission to contacts could vary over time, indicating colonization can be a dynamic
process that may be difficult to control.
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Methicillin-resistant Staphylococcus aureus (MRSA) was
first recognized in the early 1960’s as the causative agent
of some hospital-acquired (HA) infections, and now ac-
counts for the majority of HA infections in the United
States [1,2]. Community-acquired (CA)-MRSA can be
defined as a methicillin-resistant isolate acquired outside
of a hospital setting, was acquired within 2 days of hos-
pital admission, or was isolated from a person who has
not been hospitalized within 2 years prior to the date of
MRSA isolation [3]. CA-MRSA was first recognized in
the early 1990’s in Western Australia [4]. By the late
1990’s CA-MRSA [3] had spread worldwide [5], gaining
prominence after the death of 4 young children from
necrotizing pneumonia who did not have underlying risk
factors [6]. CA-MRSA has since become recognized as a
major public health concern in the United States, and
there is concern it might reach epidemic proportions
[7]. Hypervirulence and/or high rates of transmission are
trademarks of CA-MRSA, with the ability to cause dis-
ease in otherwise healthy individuals. CA-MRSA can
cause infections similar to that of HA-MRSA, such as
soft tissue and skin infections, often with abscess formation.
However, serious life threatening systemic infections,
such as necrotizing pneumonia, necrotizing fasciitis,
bloodstream infection, and septic shock can also result
from CA-MRSA [8,9].
There have been multiple reports of CA-MRSA infec-
tions on college and high school campuses, with a con-
centration of cases occurring among student athletes
[10]. Epidemiological studies have shown that coaching
staff and athletes in contact and non-contact sports, as
well as spectators, have been implicated as carriers dur-
ing outbreaks of CA-MRSA [11]. The mecA gene, which
encodes for the modified penicillin-binding protein 2a
(PBP2a) [12], is primarily responsible for methicillin
resistance in S. aureus. The mecA gene is carried on a
mobile genetic element, named the staphylococcal cas-
sette chromosome mec (SCCmec), which has integrated
into the S. aureus genome [13]. At this time, at least 11
types of SCCmec elements (I-XI) have been identified
[14]. These SCCmec elements share similar characteris-
tics, and contain a ccr (cassette chromosome recombin-
ase), which is responsible for site-specific insertion and
excision of SSCmec into the S. aureus genome at the 3’
end of the open reading frame (orfX) [15]. SCCmec
elements are differentiated based on combinations of the
types of mec and ccr genes that have been identified thus
far. The two smallest SCCmec elements are SCCmec IV
and SCCmec V, which are primarily associated with
CA-MRSA. The majority of CA-MRSA strains carry a
type 2 ccr-class B mec complex in a SCCmec IV cassette
[16]. The SCCmec IV cassette is small compared to the
SCCmec cassettes found in HA-MRSA strains, and oftenlacks other antibiotic resistance genes besides mecA [16].
Okuma et al. [16] hypothesized that the smaller size
SCCmec IV requires a lower cost of fitness than the
larger, multi-drug resistant SCCmec (normally found in
HA isolates), and as a result would favor acquisition and
retention of the cassette into the genome. CA-MRSA
strains are also more likely to carry toxin genes, including
Panton-Valentine leukotoxin (pvl), staphylococcal entero-
toxins (sea, seb, sec, sed, and see), toxic shock staphylococ-
cal toxin-1 (tst), and leukocidins (lukF-PV and lukS-PV
[lukFS-PV]), than HA-MRSA strains. However, not all
CA-MRSA strains produce these toxins [17-19].
Chambers et al. [20] specifically examined the rates of
nasal carriage of MRSA among asymptomatic athletes
and coaching staff of infected individuals, and concluded
there was little benefit to mass screening. However,
those authors suggested that surveillance of multiple
sites might improve the detection rates for colonization
of asymptomatic carriers due to the presence of distinct
flora on other areas of the body. The aim of this study
was to assess the prevalence of MRSA colonization
among athletes attending a major Division I University
and their support staff, characterize the molecular basis
of methicillin resistance in some of these isolates, and
determine if isolates were exchanged between athletes.
The persistence or variance of a genotyped strain on a
subject and within a sport throughout the course of a
12-week study was determined. We hypothesized that
participants in high contact sports or who experienced
repeated exposure to commonly used fomites (e.g. sports
equipment) would have a higher incidence of CA-MRSA
than participants in low contact sports and who used
primarily their own equipment. The results of this re-
search should be noted by coaches, athletic trainers, and
sports physicians to make them aware of the higher po-
tential for MRSA infection by some athletes, but to also
note that MRSA carriage is not restricted to the nares
and does not necessarily result in infection.
Methods
Specimen collection
Two hundred twenty-three participants were included in
the study, which included predominately college-age ath-
letes, but also 22 of the training and medical sports staff.
Athletes and staff with a prior history of MRSA infection
(within 12 months) were included and documented as
such. Two students reported previous MRSA infections
and the course of treatment was noted. All participants
were active members of a sports team during the 2007-
2008 winter/spring season unless otherwise stated and
healthy with no indication of skin or other infections at
the start of the study. Whether they lived on or off cam-
pus was noted, but not ethnicity, pets, smoking, and
whether roommates or family had a previous history of
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except for twenty-one athletes (25.8% wrestling (WTK),
26.3% baseball (BSB), 12.5% men’s track (MTK), 3.2%
women’s Lacrosse (LAX) who refused consent and were ex-
cluded. There were no incentives (see Limitations and fu-
ture work). Specimens from the anterior nares, axillary, and
inguinal regions were obtained for culture from each indi-
vidual with the BBL CultureSwab™ (BD Diagnostics, Sparks,
MD) at exactly weekly intervals for 12 weeks, as per the
manufacturer’s protocol, in the physician’s Sports Medicine
office suite. After collection, specimens were immediately
transported to the laboratory for inoculation onto culture
medium. This study was approved by the university
Institutional Review Board and was carried out exactly as
described in the approved protocol (number 2007/041).
MRSA isolation
Swabs of the anterior nares were streaked directly onto
BBL™ CHROMagar™ MRSA plates (BD Diagnostics, Sparks,
MD), which allowed positive confirmation if colonies were
mauve at 24 h and presumptive identification if coloniesFigure 1 Flowchart of isolate collection and MRSA isolation.became mauve by 48 h. At 48 h, mauve colonies were col-
lected and confirmed as S. aureus by the BBL Coagulase
Plasma test (BD Diagnostics). At the time of study CHRO-
Magar™ MRSA plates were approved for identification of
MRSA only from nasal swabs. Therefore, standard MRSA
isolation techniques were used for axillary and inguinal
swabs. Both methods have a greater than 95% specificity for
identification of MRSA-positive colonies [21]. Swabs sam-
pled from the axillary and inguinal regions were streaked
onto BBL Mannitol Salt Agar (BD Diagnostics) and incu-
bated for 24-48 h. Yellow colonies were subcultured onto
Trypticase™ Soy Agar with 5% Sheep Blood (TSA II) (BD
Diagnostics) and incubated at 35°C for 18-24 h. Following
incubation on TSA II, colonies were Gram-stained and
tested for coagulase production. Coagulase-positive strains
were then tested for resistance to oxacillin using BBL Oxa-
cillin Screen Agar (BD Diagnostics), and oxacillin-resistant
colonies were recorded as MRSA. The overall procedure
for identifying MRSA from each type of culture swab is
shown in Figure 1. When necessary, confirmation of oxa-
cillin resistance was confirmed by minimum inhibitory
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Cleveland, OH), following approved protocols (M07-A8
and M100-S22) described by the Clinical Laboratory
Standards Institute (Wayne, PA). For the purposes of
this study, an individual who was “colonized” was de-
fined as having 1-2 positive MRSA cultures over the
12-week period, while an individual who had 3 or more
positive cultures during that time period was defined
as a “persistent carrier” [22].
Strain classification using pulse-field gel electrophoresis
(PFGE)
PFGE was performed as described by McDougal et al.
[23]. Briefly, MRSA isolates were suspended in PIV buf-
fer (1 M NaCl, 10 mM Tris- HCl, pH 7.5) to an optical
density of 1.2-1.7 at 580 nm, and embedded in 1.6%
InCert agarose gel plugs (Lonza Rockland, Inc. Rockland,
ME). The cells were lysed in the plugs with lysozyme,
and the cell debris removed before enzyme digestion
with SmaI. The plugs were loaded onto a 1.2% agarose
gel for PFGE using a CHEF-DR II apparatus (Bio-Rad,
Hercules, CA). Electrophoresis parameters were 200 V
(6 V/cm), temperature 4°C, initial time 5 sec, final time
40 sec, and the total run time was 20 hr. Gels were
stained using 1.5 μl/ml of ethidium bromide. PFGE types
were assigned by matching the banding patterns of isolates
to those of the CHEF lambda DNA standard (Bio-Rad,
1703635) and to control strains of known USA type.
Photographed gel profiles were analyzed with BioNumerics
software (Applied Maths, Kortrijk, Belgium) in comparison
to established profiles of USA type strains [24].
SCCmec genotyping by PCR
Approximately 5 bacterial colonies from a single clone
were suspended in 100 μl of water and heated at 100°C
for 10 minutes to extract DNA. Multiplex PCR was per-
formed as described by Zhang et al. for SCCmec and ccr
typing [25]. Eight pairs of primers were used for SCCmec
types I, II, III, IVa, IVb, IVc, IVd, and V, 2 pairs of
primers for the mec gene, 4 primers for types 1, 2, or 3
ccr, and 1 primer pair for type 5 ccr. The primers used
were exactly those previously described for amplification
of these genes [25]. Amplification was initiated at 94°C
for 5 min followed by 10 cycles of 94°C for 45 s, 65°C
for 45 s, 72°C for 1.5 min, and then 25 cycles of 94°C for
45 s, 55°C for 45 s, 72°C for 1.5 min, and a final exten-
sion at 72°C for 10 min. PCR reactions were performed
in triplicate to reduce error.
Toxin gene identification by PCR
DNA was extracted from approximately 5 bacterial col-
onies, as described above, and 1 μl of extract containing
the DNA was added to each reaction mix. Multiplex
PCR was performed as described [26]. Briefly, primerpairs designed for amplification of sea, seb, sec, sed, see,
femA, mecA, eta, etb, and tst, were separated into 2 sets
of primer mixes, with femA included in mix B, as described
[26]. A simplex reaction containing lukFS-PV primers (F-5’
TTACACAGTTAAAGAA and R-5’ AATGCAATTGATG)
(20 pmol) was used for detection of the pvl toxin gene. The
amplification protocol was initiated at 94°C for 5 min
followed by 35 cycles of 94°C for 2 min, 57°C for 2 min,
72°C for 1 min, and a final extension at 72°C for 10 min.
The PCR reactions were performed in duplicate.
Multi-locus sequence typing (MLST)
An isolate that was untypable by multiplex PCR and
PFGE was subjected to MLST using previously pub-
lished primers and conditions [27]. MLST sequence
types were determined through the website, www.mlst.net.
A USA 300, pvl + strain was used as a control.
spa typing
To confirm results determined by PFGE and SCCmec
typing, the polymorphic X region of the spa gene was
amplified using primers spa1095F (5′-AGACGATCC
TTCGGTGAGC-3′) and spa1517R (5′-GCTTTTGCA
ATGTCATTTACTG-3′) and sequenced as described
previously [28]. The sequences were analyzed using
Ridom StaphType software version 2.2.1 (Ridom GmbH,
Germany).
Statistical analyses
Data were summarized as the median (range) for age,
class year, and number of roommates while frequency
tables were generated for the categorical variables that
included sport, residence (off campus vs. dorms), previ-
ous soft tissue infection, previous MRSA diagnosis, and
MRSA carrier status (the primary outcome). The statis-
tical null hypothesis was: there is no association between
MRSA carrier status and the hypothesized risk factors
for playing a specific sport or other category. The results
were tested using univariate and multivariate analyses.
For univariate analyses, associations between carrier sta-
tus and the demographics of age, class year, and number
of roommates were tested using the Wilcoxon 2 Sample
Test. Associations between carrier status and each type
of sport, gender, residence, and previous soft tissue in-
fection were tested using the Pearson Chi-Square Test.
The association between carrier status and a previous
MRSA diagnosis was tested using the Fisher’s Exact
Test. Data on race were not available for statistical ana-
lysis. For multivariate analyses, all the hypothesized risk
factors (excluding gender) were subjected to stepwise lo-
gistic regression modeling to select possible predictors
for carrier status. Gender was excluded from multivari-
ate analyses because it was perfectly correlated with the
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9.1; Cary, NC, USA.
Results
Prevalence of MRSA carriage
Two-hundred twenty-three subjects were enrolled in the
study. Overall, 139 total positive cultures were obtained
from 78 subjects over the 12-week study period. The
prevalence for MRSA carriage was 34.9% (78 out of 223
subjects) (Table 1). Sixty-two of the positive cultures
were obtained from the anterior nares, 19 from axillary
swabs, and 58 from the inguinal region. Of the 78 posi-
tive subjects, 19 harbored MRSA in more than one site,
and 59 were positive at only one site (22 nasal, 6 axillary,
31 inguinal). Thus, 37 of the 78 MRSA-positive partici-
pants (47%) were not colonized in the anterior nares
(data not shown; some isolates are presented in Table 2).
Univariate analysis indicated there was a signifi-
cant correlation between MRSA colonization, the sport
(76.0% [19/25] for men’s wrestling vs. 43.6% [17/39] for
men’s baseball vs. 57.1% [4/7] for women’s tennis vs.
42.1% [8/19] for women’s softball vs 30.0% [3/10] for
men’s tennis vs. 37.9% [11/29] for men’s track vs. 25.0%
[7/28] for women’s track vs. 12.5% [4/32] for women’s la-
crosse; p < 0.0001), and gender (48.5% [50/103] for men
vs. 24.5% [24/98] for women; p = 0.0004), as well as a
previous history of skin or soft-tissue infection (72.2%
[13/18] for yes vs. 35.4% [62/175] for no; p = 0.0023).
There was no statistically significant association with
residence status (36.1% [26/72] for dorms vs 42.6% [49/
115] for off-campus; p = 0.377), class year (median was 2
[second year on campus] for both colonized and non-
colonized individuals, range 1-4 and 1-5, respectively;
p = 0.709), age (median was 20 years for individuals colo-
nized with MRSA vs. 19.0 for individuals not colonized,
range for both groups 18-23; p = 0.312), or number of
roommates (median was 2.5 for individuals colonizedTable 1 Prevalence of MRSA by sport in comparison to medic
Sport played #MRSA carriers/total #
athletes enrolled per sport
percentage col
percentage col
Men’s wrestling 19/25 76.0/23.8
Men’s baseball 17/39avb 43.6/21.0
Women’s tennis 4/7 57.1/4.9
Women’s softball 8/19 42.1/9.9
Men’s tennis 3/10 30.0/3.7
Men’s track 11/29 37.9/13.6
Women’s basketball 1/12 8.3/1.25
Women’s track 7/28 25.0/4.9
Women’s lacrosse 4/32 12.5/4.9
Staff 4/22 18.1/1.8
aHomer and Lemeshow Goodness-of-Fit Chi-Square for the multivariate model was
bExcluded from the multivariate model because only 1 participant has a positive rewith MRSA vs. 2.0 for individuals not colonized, range
for both groups 0-9; p = 0.116). Only 2 participants has a
previous history of a MRSA infection, which would not
support a meaningful conclusion.
Multivariate analysis of the factors analyzed indicated that
the sport was the only predictor of MRSA colonization.
Table 1 also shows sport-specific classification using the
medical staff as the baseline. Compared with a staff preva-
lence of 18.1% (4/22), the only athletes for which
colonization with MSRA was significantly more common
than to the comparator group (medical staff) were in men’s
wrestling (76%, 19/25; adjusted odds ratio 29.7, 95% CI
5.8 – 151.5; p <0.0001) and men’s baseball (43.6%, 17/39;
adjusted odds ratio 4.4, CI 1.1 – 17.4; p = 0.036) (Table 1).
When individual sports were compared with the total num-
ber of athletes colonized with MRSA, men’s wrestling
proved to have the highest percentage of colonized partici-
pants (19 out of 25; 76.0%) (Table 1, Figure 2). Women’s
basketball had the lowest number of colonized and persist-
ent carrier participants, followed closely by men’s tennis.
There were no persistent carrier participants on the
women’s lacrosse team (Figure 2). In other sports the sport
colonization rates varied from 8.3-57.1%, and the overall
colonization rates were 1.25 to 21.0% (Table 1). However,
these numbers reflect the percent of participants who had
at least one MRSA isolate recovered during the 12-week
study. Persistent carriers (subjects with 3 or more MRSA
isolates during the 12-week test period), were observed only
in men’s wrestling and baseball (see above). The other
sport’s persistent carrier rates dropped to 2.5-13.6%, which
was not significantly different from the comparator group
(Medical Staff, data not shown). The low number of strains
carried by more than one person was likely affected by the
fact that, on average, approximately one third of partici-
pants were unavailable at the weekly collection time. There-
fore, 12 samples from each site were not able to be







29.7 (5.8 – 151.5) <0.0001
4.4 (1.1 – 17.4) 0.036
4.2 (0.6) – 29.4) 0.143
4.1 (0.9 – 19.0) 0.069
3.8 (0.6 – 22.0) 0.140
3.5 (0.8 – 14.6) 0.091
N/Ab N/Ab
2.0 (0.4 – 8.9) 0.371
0.8 (0.2 – 4.2) 0.832
1 (reference group) -
0.000 (P = 1.000) indicating a good fit.
sult for MRSA.
Table 2 Molecular characteristics of 32 MRSA isolates carried by winter/spring athletes at a Division I University
Isolate source PFGE typea spa type Multiplex typing PCRb
Sportc Participant # Week Sampling sited ccr-mec SCCmec Type Toxin gene profile
WR 35 5 I USA700 n/d 2-B IVb eta, lukFS-PV
WR 41 6 I USA700 n/d 2-B IVb eta, lukFS-PV
WR 41 10 I USA700 n/d 2-B IVb eta, lukFS-PV
WR 47 3 A Unknowne t216 2-B Undeterminedf seb, sed, etb, tst, lukFS-PV
WR 52 5 I USA500 txAA 2-B IVb sea, see, eta, lukFS-PV
WR 52 6 I USA700 n/d 2-B IVb eta
WR 55 2 N USA300 t008 2-B IVd none detected
WR 55 3 N USA300 t008 2-B IV lukFS-PV
WR 55 3 A USA300 t008 2-B IVa etb, tst, lukFS-PV
WR 55 5 N USA300 t008 2-B IV lukFS-PV
WR 55 7 I USA300 t008 2-B IV sec, etb, tst, lukFS-PV
WR 55 7 N USA300 t008 2-B Undeterminedf eta, lukFS-PV
WR 55 8 N USA300 n/d 2-B IV etb, tst, lukFS-PV
WR 55 8 I USA300 t008 2-B IV etb, tst, lukFS-PV
WR 57 1 N USA400 t128 2-B IVa sea, see
WR 57 3 N USA400 t128 2-B IVa seb, sec, sed, see, etb, tst, lukFS-PV
WR 57 5 N USA400 n/d 2-B IVa seb, sec, see, etb, tst, lukFS-PV
WR 57 8 N USA400 t128 2-B IVa eta, lukFS-PV
WR 57 9 N USA400 n/d 2-B IVa seb, see, eta
WR 57 12 N USA400 n/d 2-B IVa seb, see, lukFS-PV
WR 65 12 N USA800 t088 2-B Undeterminedf tst
WR 81 6 N USA800 t002 2-B Undeterminedf lukFS-PV
SB 86 1 I USA400 t008 2-B IVa sea, see, eta, lukFS-PV
SB 90 1 N USA800 n/d 2-B IVd etb, lukFS-PV
SB 90 5 I USA800 t002 2-B Undeterminedf etb, lukFS-PV
SB 90 5 N USA800 t128 2-B Undeterminedf lukFS-PV
SB 90 7 N USA800 n/d 2-B IVd eta, lukFS-PV
SB 90 8 N USA800 t002 2-B IVa lukFS-PV
BSB 108 5 A USA300 txAB 2-B IV etb, lukFS-PV
BSB 108 11 I USA300 t334 2-B IVd lukFS-PV
BSB 111 1 I USA300 t008 2-B IVa sec, etb, tst, lukFS-PV
WBB 234 1 I USA400 n/d 2-B IVa seb, see, eta
aPFGE patterns were assigned as described [23].
bMultiplex PCR for SCCmec and ccr typing was carried out as described [25], and for toxin gene identification [26].
cWR: Wrestling, SB: Softball, BSB: Baseball, WBB: Women’s Basketball.
dSampling site: I, inguinal; A, axillary; N, nasal.
eUnknown PFGE pattern; MLST was identified as ST951.
fFailed to specifically subtype using primers for SCCmec I-IV.
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in statistical analyses. Medical staff screening yielded 4
MRSA colonized participants among a total of 22 partici-
pants (18.2%).
PFGE analysis
Of the 139 MRSA isolates collected, 32 confirmed
MRSA isolates were selected for further characterizationbased on repeated participant colonization or based on
participation in a sport with a high persistent carriage
rate. The 32 MRSA isolates further tested were from 13
individuals and consisted of five different pulse-field
types (PFT): USA300, USA400, USA500, USA700, and
USA800 [23] (Table 2 and Figure 3). Of the 13 partici-
pants represented in Table 2 from whom MRSA isolates
were characterized, 6 were colonized with USA300/400
Figure 2 Prevalence of MRSA colonization in athletes by sport. Men’s wrestling had the highest percentage of MRSA carriers (19 out of 25
participants or 76.0%). In other sports, 8.3-57.14% of participants carried MRSA. Athletes participating in men’s wrestling (p = 0.0023) and men’s
baseball (p = 0.036) were statistically significant for colonization with CA-MSRA. WR: wrestling, BSB: baseball, MTN: men’s tennis, WTN: women’s
tennis, WBB: women’s basketball, SB: softball LAX: women’s lacrosse.
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the participants were colonized with USA700 MRSA iso-
lates (one participant was also colonized with USA500
[Figure 3]) and 3 were colonized with USA800 MRSA
isolates. One isolate (a wrestler’s axillary isolate; 47A-3)
was not classified into any of the known USA strain des-
ignations after digestion with SmaI and PFGE.
SCCmec typing
All of the isolates tested that could clearly be typed har-
bored SCCmec IV (Table 2). Of the 26 isolates con-
firmed to harbor SCCmec IV, subtyping was successful
in 20 of these. Eleven were subtype IVa, 5 were subtypeFigure 3 Examples of SmaI-PFGE banding patterns of MRSA isolates.
500 and 700, representing USA types USA500 and USA700, were isolated fr
molecular size standards; C1, control MRSA strain BAA1685, type USA200; C
isolate; 400, type USA400 isolate; 500, type USA 500 isolate; 700, type USA7IVb, and 4 were subtype IVd. None of the isolates har-
bored SCCmec IVc. Of the isolates tested in this study
(Table 2), six isolates (47A-3, 55 N-7, 65 N-12, 81 N-6,
90I-5, and 90 N5) were unable to be classified into a
known SCCmec type using primers for SCCmec I-IV,
and IVa-IVd, which is not uncommon [29]. Since the
completion of this study several new SCCmec types have
been discovered indicating the vast genetic diversity of
the SCCmec, and it is possible these undetermined iso-
lates could be a newer type not tested for. Isolates 90I-5
and 90 N-5 were from the same baseball participant on
the same collection date, but from different sites. All iso-
lates tested were of ccr-mec type 2-B.The PFGE-tenable isolates were categorized into 5 USA types. Lanes
om the inguinal site of the same individual 1 week apart. Lanes: M,
2, control MRSA strain BAA1556, type USA300; 300, type USA300
00 isolate; 800, type USA800 isolate.
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The unclassified isolate 47A-3 was subjected to MLST
typing and was identified as a clonal type of ST951. This
same isolate was also found to be spa type t216. There
are no previously published MRSA strains with these
two profiles. Isolate 47A-3 could be a novel S. aureus
strain, and may be the reason it did not fall into a previ-
ous classification type by PFGE or SCCmec typing. Iso-
lates that exhibited clonal variation within a subject over
the 12-week period or those isolates that were untype-
able by either previous method were also selected for
spa typing. Twenty-one isolates were tested, which were
classified into 8 spa types. Three subjects encompassing
9 of the isolates tested were spa type t008. Six of these
isolates were from subject 55 and all were of PFGE type
USA300. The spa types t128 and t002 were each found
in the same softball subject, but from two different sites
obtained on the same date (nares and inguinal); both
strains were USA800 and were of unclear SCCmec type.
The spa types t128 and t002 were also isolated from two
different wrestlers. The spa types t216, t088, t334, txAB,
and txAA (the latter two are novel spa types) were
recovered only once, but may have been represented in
isolates not tested.
Detection of toxin genes
Nine staphylococcal toxin genes were detected among
the 32 MRSA isolates analyzed (Table 2). The most com-
mon were lukFS-PV (Panton-Valentine leukocidin) (81%;
26 of 32 isolates; 19% of isolates tested positive for only
lukFS-PV), and the exfoliative toxins eta (34%, 11 of 32
isolates), and etb (34%; 11 of 32). Other toxin genes de-
tected included the enterotoxin genes see (25%, 8 of 32),
sea (9%, 3 of 32), seb (19%, 6 of 32), sec (13%, 4 of 32),
and sed (6%, 2 of 32). Nine isolates carried the toxic
shock toxin gene tst (28%). A single nasal isolate (55
N-2) carried by participant 55 had no toxin genes, but
other isolates recovered from participant 55 over the 12-
week study were positive for the presence of multiple
toxin genes.
Isolate variation over time
Isolates from several participants who were repeatedly
colonized with MRSA were characterized in order to
identify isolate changes over 12 weeks. Wrestling partici-
pant 55 carried one clone: USA300 of spa type t0008 for
8 weeks. Wrestling participant 57 was colonized with
MRSA for 6 of 12 weeks; all isolates were USA400
clones, spa type t128. Five isolates from participant 90
were USA800 isolates, but of those tested, two different
spa types were identified: t002 and t128. Similarly, two
isolates from baseball participant 108 were both of
USA300, but of distinct spa types. In addition, two dif-
ferent USA types were identified from wrestler #52,1 week apart, and both were from the inguinal region
(Table 2). Throughout the study, isolates were recovered
from these participants that had varying toxin gene pro-
files. Of those harboring isolates with toxin genes, the
most prevalent throughout were seb, see, and lukFS-PV.
Isolate characteristics were also examined between
participants within the same sport. Two transiently colo-
nized wrestling participants had the same USA700 clone
containing eta and lukFS-PV toxin genes. Participant 55
was colonized for 8 weeks with a USA300 clone, but dif-
ferent toxin genes were identified in the isolates. Of the
22 MRSA isolates from wrestlers that were genetically
characterized, there were 5 different clones (USA300,
400, 500, 700, and 800) and one unidentifiable isolate
type. Participant 57 was continuously colonized with a
USA400 clone, while participants 65 and 81 were transi-
ently colonized with a USA800 isolate with varying toxin
genes (data not shown). The isolates analyzed from base-
ball participants were all from a USA300 clone that car-
ried varying toxin genes. From our study, it is unclear
whether this was one USA300 clone that gained or lost
toxin genes throughout the 12 weeks or separate clones
of USA300. The genes lukFS-PV were the only toxin
genes consistently identified from all the isolates from
baseball participants. However, because up to one-third
of the participants were not available for culture each
week, the persistence or variation of isolates from a
given athlete were incomplete.
Discussion
During the past 15 years CA-MRSA isolates have been
recovered from otherwise healthy individuals outside of
the hospital setting. Infections due to CA-MRSA can
be unpredictable, invasive, and more deadly than HA-
MRSA. As a result, infections with such isolates must be
carefully monitored, and the risks due to carriage and
transmission of such isolates require further investiga-
tion and understanding. The prevalence of MRSA infec-
tions in athletes can be much higher than the general
population, particularly in athletes in contact sports [30].
However, there are a lack of data regarding the preva-
lence of MRSA carriage in healthy college athletes, and
the molecular characterization of such isolates. Our
study sought to address the prevalence and molecular
types of MRSA in this population.
It is well established that the anterior nares serves as a
reservoir for S. aureus [31-33]. Several studies have ex-
amined the colonization rates of both symptomatic and
asymptomatic athletes and spectators. The largest group
studied has been American football players. Nguyen et
al [30] reported an outbreak of CA-MRSA skin and soft
tissue infections in 11 players on a college football team.
Cultures of the anterior nares only identified 26 of 99
healthy players carrying S. aureus, of which 8% were
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than multiple samples over 12 weeks, as in this study. In
our study the overall colonization rate of MRSA in all
athletes and their support staff was 36.8%. Begier et al.
[34] reported an outbreak of MRSA infection among
college football players due to a USA300 clone that was
positive for the lukFS-PV genes. Nasal swabs were col-
lected from the athletes and staff, but none were found
to carry MRSA. However, 48.5% were colonized with
MSSA. Kazakora et al. [11] reported similar findings in
regard to an outbreak of MRSA infections in a profes-
sional football team. Nasal swab cultures were collected
from all athletes, but again MRSA carriage was not
found. [34]. It is likely these participants were carrying
MRSA, but in sites other than the anterior nares. Al-
though the number of participants per sport was rela-
tively small, and ethnicity, socio-economic background,
or family history of MRSA infection was not noted, this
study was distinct in that there had been no reported
outbreak of MRSA in the population we examined, and
only one active infection with MRSA occurred during
the 12-week study. A novel aspect of our study was con-
tinuous sample collection from 3 anatomic sites over a
12-week period, as opposed to a one-time nares-only
collection, as in previous studies [11,34]. We expected
that culturing multiple sites would identify a higher rate
of transient MRSA colonization. Transient MRSA isolation
was evident in multiple participants throughout the study,
either with the same MRSA isolate (e.g. participant #s 41,
55, 57) or with varying isolates (e.g. participant #s 52, 90,
108). However, the profile of persistent or transient carriage
of a particular isolate by a participant was incomplete due
to a substantial number of participants not being available
for culture on any given week.
As reported in previous studies [10,11], athletes in
contact sports have higher carriage rates of MRSA. In
fact, participants in sports involving greater physical
contact, have the most significant carriage rate for
MRSA. In our study, of the parameters examined, the
sport was the only predictor of MRSA colonization. The
highest colonization rate was associated with the contact
sport wrestling, followed by baseball. Athletes participat-
ing in football were not tested because only athletes par-
ticipating in Spring sports were involved in this study.
However, the sport with the lowest level of colonization
was women’s basketball, and no participants in women’s
lacrosse were found to be persistent carriers. Since less
contact would be expected in baseball than in basketball
or lacrosse (though not to the level of contact in wrestling)
gender may also be a factor in CA-MRSA colonization.
Nonetheless, these results suggest that athletes who have
more physical contact with commonly used fomites or
teammates may need to be monitored more closely for
signs of potential MRSA infections.In the United States, MRSA clones USA300, USA400
and often USA700 are the most prevalent and carry the
SCCmec IV cassette [23]; USA300 is currently respon-
sible for the majority of morbidity and mortality associ-
ated with MRSA, particularly in athletes [6,10]. Of the
select isolates represented in Table 2, MRSA carriage
among the athletes in this study followed the same pat-
tern; all isolates from which a clear SCCmec type could
be identified were confirmed to carry a SCCmec IV cas-
sette, which is most commonly found in USA300 and
USA400 clones. As expected, USA300/400 clones made
up over 69% of the confirmed type IV isolates tested. Of
the 13 participants from whomMRSA isolates were charac-
terized, 6 were colonized with USA300/400 MRSA types.
Of interest was that in this population 3 of the participants
were colonized with USA700 MRSA isolates and 3 were
colonized with USA800 MRSA isolates. Although strains of
USA700 commonly occur in the community, USA800 iso-
lates are more often associated with hospital-acquired in-
fections, but community isolates are not uncommon [23].
Furthermore, Stevens et al. reported the presence of
USA800 from women’s collegiate basketball players [35].
Unfortunately, we did not determine if any of the partici-
pants from whom USA800 isolates were recovered had vis-
ited a hospital or were in contact with people who had
been hospitalized or had visited a hospital. However, one
isolate could not be classified into an established USA type
by PFGE or PCR, but was determined to be a novel MLST
and spa type. This was the only MRSA isolate from this in-
dividual, and therefore due to its transient nature its signifi-
cance cannot be determined. The most common spa type
found among these isolates was t008, which represents only
5.99% of isolates in the Ridom SpaServer database
(http://www.spaserver.ridom.de), but in our study type
t008 had a much higher frequency (42.8% of isolates
typed and 3 of 13 participants studied). The t008 type
corresponds to the common USA300 clone, and all of
the USA300 isolates characterized in this study were
spa type t0008, as well as one USA400 type. The two
other spa types found in multiple participants were
also more common than what is represented in the
Ridom database: t002 accounted for 14.2% of our iso-
lates (6.4% average) or in 2 of 13 participants studied.
The spa type t128 accounted for 19% of our isolates
(0.05% average) or in 2 of 13 participants studied
(http://www.spaserver.ridom.de).
We were also interested in determining if MRSA iso-
lates from healthy participants carried any of the
staphylococcal toxin genes, and if so which ones. We de-
tected 9 toxin genes among the 40 MRSA isolates tested.
The most common genes found were lukFS-PV, eta, and
etb. The lukFS-PV genes encode for the Panton-Valentine
leukocidin toxin. MRSA isolates carrying these genes have
been shown to be responsible for more severe disease and
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[36]. The eta/etb genes encode for exfoliative toxins that
may enhance the transmission/progression of a MRSA in-
fection through skin-skin contact, due to the destruction of
the epidermal barrier [37]. However, during the course of
this study only 1 athlete developed a MRSA infection.
Although the presence and expression of toxin genes may
potentially make the bacteria more virulent following infec-
tion, there was no correlation between the presence of
toxin genes and predisposition to infection in these athletes.
Therefore, other predisposing conditions may be necessary
to initiate infection.
Most participants were not colonized with the same
clone continuously throughout the study, nor were they
colonized in the same site. While it is quite possible that
the presence of MRSA was missed on a particular cul-
ture or due to a participant’s occasional absence, the
variation in toxin genes further suggested that some
participants may be prone to carriage or colonization
with MRSA, but that residence by individual clones
varies. Thus far, studies are lacking that have followed
colonization of healthy individuals over time with MRSA
to evaluate the persistence of individual strains on a
subject over time. Such results have not been commonly
reported because most studies have examined MRSA
from infected individuals, rather than the prevalence of
carriage and colonization in a healthy population. Based
on PFGE analysis, it was apparent that strains were
transmitted between teammates participating in wrest-
ling and baseball. The mechanism of such transmission
was not determined, but is likely through direct contact
(particularly in sports such as wrestling) or indirectly
through common contact with contaminated fomites
(which may occur in locker rooms or handling common
pieces of equipment).
Conclusions
This study indicated that participants in sports are more
likely to carry or be colonized with MRSA than the general
population, that such carriage may occur in multiple sites
other than the nares, and that transient colonization with
different strains was common. Precautions to minimize
transmission of MRSA between athletes or equipment and
facilities used by athletes and staff may be warranted.
Limitations and future work
A questionnaire was given to each participant asking
about residence, previous history of skin or soft tissue
infection within 12 months and any previous history of
MRSA diagnosis. The specific participants with previous
MRSA infection history were not identified to those
processing the samples. Therefore, we know only that 1
baseball player and 1 wrestler were previously infected with
MRSA. Comparisons between these previously infectedindividuals and other athletes are lacking. Due to partici-
pants scheduling conflicts, twelve weeks of sample collec-
tions were not completed on all participants. Future work
could include molecular characterization on all 139 MRSA
isolates. This could allow for more in-depth comparisons of
isolates shared between sports, or comparison of staff
versus sport participants.
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